LENZ Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover LENZ Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $44, which forecasts a 373.63% increase in the stock price over the next year. The lowest target is $26 and the highest is $67.

Price Target: $44 (+373.63%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$26	$44	$48	$67
Change	+179.87%	+373.63%	+416.68%	+621.21%

Analyst Ratings

The average analyst rating for LENZ Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	3	3
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $56 → $48	Strong Buy	Maintains	$56 → $48	+416.68%	Apr 21, 2026
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $52 → $26	Strong Buy	Maintains	$52 → $26	+179.87%	Mar 26, 2026
Jason Gerberry B of A Securities	B of A Securities	Strong Buy Maintains $35 → $29	Strong Buy	Maintains	$35 → $29	+212.16%	Mar 25, 2026
Gary Nachman Raymond James	Raymond James	Buy Reiterates $40 → $50	Buy	Reiterates	$40 → $50	+438.21%	Oct 20, 2025
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $51 → $67	Buy	Maintains	$51 → $67	+621.21%	Oct 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

28.71M

from 19.09M

50.42%

from 19.09M

Revenue Next Year

85.32M

from 28.71M

197.16%

from 28.71M

EPS This Year

-3.87

from -2.85

EPS Next Year

-2.69

from -3.87

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	15.00M	-	-	19.09M	28.71M	85.32M
Revenue Growth	-	-	-	-	-	50.42%	197.16%
EPS	-0.81	-1.14	-35.71	-2.34	-2.85	-3.87	-2.69
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	45.9M	139.2M
Avg	28.7M	85.3M
Low	16.1M	52.2M

Revenue Growth

Revenue Growth	2026	2027
High	140.4%	384.8%
Avg	50.4%	197.2%
Low	-15.8%	81.9%

EPS Forecast

EPS	2026	2027
High	-2.81	-0.64
Avg	-3.87	-2.69
Low	-4.60	-3.40

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.